Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1511600
PUBLISHER: GlobalData | PRODUCT CODE: 1511600
Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
PUBLISHED:
PAGES: 60 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's Medical Devices sector report, "Arteriotomy Closure Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Arteriotomy Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention or a peripheral intervention. Arteriotomy closure devices are used to decrease vascular complications and reduce the time to hemostasis and ambulation compared to the traditional methods such as manual or mechanical compression.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Arteriotomy Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Arteriotomy Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Arteriotomy Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1760EPD
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 Arteriotomy Closure Devices Overview
3 Products under Development
- 3.1 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
- 3.2 Arteriotomy Closure Devices - Pipeline Products by Segment
- 3.3 Arteriotomy Closure Devices - Pipeline Products by Territory
- 3.4 Arteriotomy Closure Devices - Pipeline Products by Regulatory Path
- 3.5 Arteriotomy Closure Devices - Pipeline Products by Estimated Approval Date
- 3.6 Arteriotomy Closure Devices - Ongoing Clinical Trials
4 Arteriotomy Closure Devices - Pipeline Products under Development by Companies
- 4.1 Arteriotomy Closure Devices Companies - Pipeline Products by Stage of Development
- 4.2 Arteriotomy Closure Devices - Pipeline Products by Stage of Development
5 Arteriotomy Closure Devices Companies and Product Overview
- 5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
- 5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.2 Arterica Inc Company Overview
- 5.2.1 Arterica Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.3 CardioDex Ltd (Inactive) Company Overview
- 5.3.1 CardioDex Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
- 5.4 CaveoMed GmbH Company Overview
- 5.4.1 CaveoMed GmbH Pipeline Products & Ongoing Clinical Trials Overview
- 5.5 CloSys Corp Company Overview
- 5.5.1 CloSys Corp Pipeline Products & Ongoing Clinical Trials Overview
- 5.6 CPC of America Inc Company Overview
- 5.6.1 CPC of America Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.7 CyndRX LLC Company Overview
- 5.7.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
- 5.8 Dextera Surgical Inc Company Overview
- 5.8.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.9 Genesis MedTech International Pvt Ltd Company Overview
- 5.9.1 Genesis MedTech International Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.10 Harvard University Company Overview
- 5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
- 5.11 Lepu Medical Technology (Beijing) Co Ltd Company Overview
- 5.11.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.12 Nanjing SealMed Medical Technology Corp Ltd Company Overview
- 5.12.1 Nanjing SealMed Medical Technology Corp Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.13 NewMed Medical Co Ltd Company Overview
- 5.13.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.14 ProMed Inc Company Overview
- 5.14.1 ProMed Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.15 Rex Medical LP Company Overview
- 5.15.1 Rex Medical LP Pipeline Products & Ongoing Clinical Trials Overview
- 5.16 Shanghai HeartCare Medical Technology Co Ltd Company Overview
- 5.16.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.17 Spiorad Medical Ltd Company Overview
- 5.17.1 Spiorad Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
- 5.18 Terumo Interventional Systems Company Overview
- 5.18.1 Terumo Interventional Systems Pipeline Products & Ongoing Clinical Trials Overview
- 5.19 University of Rochester Company Overview
- 5.19.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
- 5.20 Vascular Closure Systems Inc Company Overview
- 5.20.1 Vascular Closure Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
- 5.21 Vivasure Medical Ltd. Company Overview
- 5.21.1 Vivasure Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
- 5.22 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
- 5.22.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6 Arteriotomy Closure Devices- Recent Developments
- 6.1 Apr 15, 2024: Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System
- 6.2 Dec 12, 2023: Vivasure Medical Announces First Patients Treated with PerQseal Elite Closure Device System
- 6.3 Nov 17, 2023: Teleflex enrols first patient in MANTA device trial
- 6.4 Nov 14, 2023: Vivasure Medical Announces 100th Patient Enrolled in U.S. Pivotal Study
- 6.5 Aug 29, 2023: Haemonetics Announces European Expansion for VASCADE Vascular Closure System
7 Appendix
- 7.1 Methodology
- 7.2 About GlobalData
- 7.3 Contact Us
- 7.4 Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.